Point of Care Strep Tests Speed Treatment, Lower Costs
...iminating the need for test tubes and reducing the number of steps. This test exhibits a 93 percent accuracy compared to plate culture. The QuickVue In-Line Strep A Test from Quidel Corporation, San Diego, Calif., also allows for the rapid detection of group A streptococcal antigen directly from patien...Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
...levated white blood cell count, an increased total number of lymphocytes and greater than 10 percent atypical lymphocytes. In keeping with the rapid proliferation of point-of-care diagnostic kits and devices, several products have now been CLIA-waived by the Centers for Disease Control and Prevention (CDC)....Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse
...assay can be used for large batches of samples. A number of single use devices incorporating immunoassays and designed to be used outside of the traditional laboratory have become available. These devices require FDA approval to be sold in the United States, and their use in non-medical environments such a...Lab Automation Networks Proliferating
...ave stimulated decisions to automate an increasing number of pre-analytic functions or distinct workcell areas. Several hundred clinical labs worldwide have even taken the giant stride of converting to total laboratory automation, based on strong evidence that automation not only heightens profitability but...The Past, Present and Future of HLA Typing
... average turnaround time, required resolution, and number of average samples per day. For those laboratories with access to Sequencers, it may be the most sensitive, specific and cost effective option to sequence certain HLA loci directly. And as more and more diseases are linked to specific HLA polymorp...New Assays to Detect Disseminated Fungal Infections
... to be discovered only at autopsy. Fortunately, a number of new assays offer solutions to these problems. F...ent of the fungal cell wall. Glucan is found in a number of medically important fungi such as Candida , Aspergillus , Fusarium, Acremonium, and Saccharo...Testing for Human Papillomavirus
...roximately 50 anogenital HPVs, there are a limited number of high and intermediate risk types detected in anogenital cancer biopsy specimens. Worldwide, HPV has been associated with 99.7% of squamous cell cancers of the cervix. Most genital HPV infections in women produce transient squamous cell abnormalit...Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
...nt CYP subtypes. The first, CYP2D6, metabolizes a number of medications, including antidepressants, anti-ps...mpanies such as Nanogen also continue to develop a number of microarray-based tools. Together, these advances will make tailored drug therapy a reality, and ...Appendicitis: Evolving Tools to Diagnose a Classic Disease
...ule out appendicitis definitively. Fortunately, a number of laboratory and imaging modalities, some new and sophisticated, can improve levels of clinical confidence. Ideally, these tools should provide optimal positive predictive value to facilitate early appendectomy, all in an effort to reduce mortali...Avian (Bird) Flu: Is There a Role for Rapid Tests?
...suspected. These guidelines (link below) convey a number of important points. Overall, information is limi...be tested on multiple days. The FDA has approved a number of rapid tests for influenza A. In theory, any of these products can detect the H5N1 subtype, but i...Managing Preanalytical Processes for Patient Safety
...vice indicates the collection details, such as the number and types of tubes, and order of draws. The phlebo...specimen are around 75 cents. Multiply that by the number of specimens that require re-labeling, and the cost can be astronomical. The opportunity for error i...Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal
...nhealthy distribution of particles. Accordingly, a number of tests have been developed that focus on lipid particle size and density. The Lipoprint (Quantimetrix) was designed to do just that. The test uses a gel electrophoresis method to examine lipoprotein subfractions, including 12 cholesterol paramete...Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
...portance. The study showed that lowering the HbA1c number can potentially reduce the development of complications and that lowering HbA1c levels by any amount improves a person's chances of staying healthy. All HbA1c tests are not the same, but there is an ongoing international effort to standardize them by...Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
...ineer was tasked with counting plankton in a large number of seawater samples. He devised a dual chamber con...based upon known cell-surface markers. Because the number of cells counted by an automated system is many times greater than the number countable by eye in a ...Rapid HIV Testing Increases Possibility of Treatment
...n HIV/AIDS) and the World Health Organization, the number of people living with HIV globally reached an esti...and unaware of their status. To address the large number of people who are unaware of their status, considerable progress has occurred in prompt, definitive ...Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing
... such as blood transfusions, is based on a certain number of laboratory results. Transfusion strategies (red blood cells and platelet concentrates) rely on almost daily CBC monitoring in addition to screening for irregular agglutinins in transfusion cases or measuring markers of other vital functions in ch...Optimizing Quality Control Data Management
...s to improve analytical performance and reduce the number of false rejections: Imprecision based upon Biological Variation and State of the Art help the laboratory confine imprecision within defined limits. Medical Relevance can be used to distinguish between statistical error and a medically important ch...Urinalysis Analyzers: Large Capabilities in Every Size Device
...with the integrated keypad, along with a secondary number that can be used sequentially or adjusted to be the instrument, location or operator identification. List price for the PocketChem is $625. Hypoguard USA, Inc., Edina, Minn., a division of British firm Medisys, manufactures the DiaScreen 50 Urine Che......regulatory process, changes in markettrends, and a number of other factors and risks described from timeto time in the Company's filings with the Securities and ExchangeCommission. Contact RBC Life Sciences, Inc. Steve Brown, CFO, 972-893 4000 <a target="_blank" href="mailto:sbrown@rbcls.com">stev......hey used state populations to calculate theaverage number of prescriptions written per person. Researcher...rescribed per 1000 persons in the U.S. The highest number ofprescriptions per 1000 persons was in Massachusetts with 11.8.Hawaii had the lowest with 2.7 presc...Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
...e forward looking statements that are subject to a number ofrisks and uncertainties that could cause actual results to differmaterially from results, performance or achievements expressed orimplied by such statements. These risks and uncertainties may beassociated with product discovery and development, inc...... 1 IU/dL withprophylactic therapy may decrease the number of bleeding episodes,particularly in children. "U...ins and coauthors were able to estimate the median number ofhours per week spent below the 1 IU/dL trough level for eachpopulation, 19.7 hours and 16.5 hours ......rf stockexchange under the symbol B8F and the ISIN number DE0006046113.<a target="_blank" href="http://www.biofrontera.com/">http://www.biofrontera.com/ This press release contains forward-looking statements based onthe currently held beliefs and assumptions of the management ofBiofrontera AG, whi......s have been shown to be very active clinicallyin a number of tumor types. However, they are usually associat... includes forward-looking statements thatinvolve a number of risks and uncertainties, the outcome of whichcould materially and/or adversely affect actual futu......r injected drugs and fluids. TheCompany also has a number of different enzymes in its portfoliothat are targeting significant areas of unmet need. Safe Harbor Statement In addition to historical information, the statements set forthabove include forward-looking statements (including, withoutlimitation, st...... or 70%) in certain RA symptoms and measures the number of tender and swollen joints, pain, patient's and physician's global assessments and certain laboratory markers. An ACR70 response is considered exceptional and represents a significant improvement in a patient's condition...Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimer's Disease
...zheimer's disease still remains unknown, a growing number ofresearchers are indicating that plaque formation and accumulationmay play a role. The study was conducted by Samaritan's collaboratingresearchers, including Dr. Laurent Lecanu and Dr. VassiliosPapadopoulos. Abstract: <a target="_blank" hre...Protox Announces Positive Clinical Data from Prostate Cancer Study
...n in study patients, as well as a reduction in the number of positive biopsies after treatment.Second, there...er the reservationnumber 21240373 followed by the number sign. A live audio webcastof the conference call will be available at <a target="_blank" href='...SuperGen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
...ematologicalmalignancies. SuperGen is developing a number of therapeuticanticancer products focused on kinase and cell signaling inhibitorsand DNA methyltransferase inhibitors. For more information aboutSuperGen, please visit <a target="_blank" href="http://www.supergen.com/">http://www.supergen.com...Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
...orationwith leading pharmaceutical companies, in a number of diseaseareas, including epilepsy; pain; inflamm... contains forward-looking statements thatinvolve a number of risks and uncertainties. For this purpose, anystatements contained herein that are not statements......nstance, VTE prophylaxis has beenidentified as the number #1 strategy to improve patient safety inthe hospit...as the scientificcoordinating center for a growing number of national andinternational outcomes registries. COR's responsibilities includemaintaining patient ......e world's leading pharmaceuticalcompanies, ranking number one in Europe. Backed by a world-classR&D organisation, sanofi-aventis is developing leadingpositions in seven major therapeutic areas: cardiovascular,thrombosis, oncology, metabolic diseases, central nervous system,internal medicine and vaccines......current therapies andhelp to treat the significant number of under- and un-treatedpatients at risk for life-threatening thrombotic events." The trade name of rivaroxaban is expected to be Xarelto(R),pending health authority approval. Results from other phase III trials in the RECORD program,RECORD1 and RE...Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
...of vitamin D,which has been clinically tested in a number of solid tumortypes. Further information about Co... current information andexpectations and involve a number of risks and uncertainties.Actual events or results may differ materially from those projectedin any......risk for the disease.Over the next five years, the number of people suffering fromosteoporosis is expected to reach 52 million, creating a $10.4billion market by 2011. About the ViaDerm System TransPharma's ViaDerm drug delivery system incorporates ahandheld electronic control unit combined with a drug pa...Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
...gement's current expectations and are subject to a number offactors and uncertainties, which could cause actual results todiffer materially from those described in such statements. Wecaution investors that actual results or business conditions maydiffer materially from those projected or suggested inforward......ach has the potential to treat CDAD and reduce the number ofdisease recurrences, resulting in improved quality of life for thepatient and significant savings to the healthcare system. About the PACT Study The PACT study, which involved more than 1,100 patients atapproximately 300 sites in North America, E...New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
...e Lancet article.Kaiser Permanente had the highest number of enrollees in the studyfrom the United States. Dr. Towner said that the ongoing 'DUET-2' trial -- large,randomized, and placebo controlled -- is the pivotal registrationand efficacy trial for TMC125 (it is in a class of HIV drugs callednon-nucleos......ilar expressions. Thesestatements are subject to a number of risks, uncertainties andother factors that could cause actual events or results in futureperiods to differ materially from what is expressed in, or impliedby, these statements. DOR cannot assure you that it will be able tosuccessfully develop or c...... the hormone progesterone wasshown to increase the number of growing tumors. Conversely, theadministration o... in the United States and results in a significant number ofhysterectomies each year. Proellex has recently completed asix-month European Phase 1/2 study for ...Avexa's Apricitabine Clinical Trial Update
...apricitabine is welltolerated in HIV patients. The number of patients requesting toenter the extension study after the 48 week trial to continuetreatment with apricitabine is an indicator of the important rolethat apricitabine will play in the management of HIV.Apricitabine's clinical development remains on......ent treatment optionsare insufficient. Suven has a number of programs in each of theseareas, focusing on nov...se may be forward-lookingstatements that involve a number of risks and uncertainties.Although Suven attempts to be accurate in making theseforward-looking sta...Genzyme Announces Results of Clinical Trial of Hylastan
...d the benefits ofviscosupplementation to a broader number of patients. Genzyme's development program also includes Synvisc-One(TM), aninvestigational combined-dose regimen of Synvisc(R) (hylan G-F 20)provided in a single injection, which the company is currentlyseeking to market in the United States and Eu...Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
...rities LitigationReform Act of 1995 that involve a number of risks anduncertainties. There can be no assurance that such statements willprove to be accurate and the actual results and future events coulddiffer materially from management's current expectations. Theconduct of clinical trials and the developme...Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
...xic side effects in normal cells. Theyexpanded the number of mesenchymal stem cells in the laboratory andthen used a retrovirus vector to insert the gene cytosine deaminaseinto the cell. This gene can convert a less toxic drug, 5-fluorocytosine (5-FC), to 5-FU inside the stem cells, andthe chemotherapy can ......ge at onsetof menses, age at birth of first child, number of previous breastbiopsies, presence of atypia, and number of close relatives withbreast cancer. While the Mayo Clinic study found that family history did n...Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
... patients is Tobramycin but there are anincreasing number of Tobramycin resistant strains of Pseudomonas.The...mpliance with the study protocol, and a sufficient number ofpatients completing the studies; the ability of the company tocommercialize its planned products; ...Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
...ble in themajor markets. However, entacapone has a number of drawbacks,namely a short half-life, relatively ...series has beenachieved by CeNeS scientists, and a number of discrete chemicalseries without the nitrocatechol group have been identified. TheCOMT inhibitor p......ilar expressions. Thesestatements are subject to a number of risks, uncertainties andother factors that could cause actual events or results in futureperiods to differ materially from what is expressed in, or impliedby, these statements. DOR cannot assure you that it will be able tosuccessfully develop or c...Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
...tinent, percent of heavydrinking days, and average number of drinks per day. ALKS 29 wasgenerally well toler...ays abstinent, percent of heavy drinking days, and number ofdrinks per day. Heavy drinking is defined as five or more drinksper day for men and four or more d......erially from those projected hereinand depend on a number of factors, including the uncertaintiesrelated to the regulatory process and the commercialization of theCompany's products, if they are approved, specifically, theadoption of such products by physicians and patients.. Investorsshould consult the Com......om our trialin a press conference. Considering the number of studies presentedon Europe's largest cancer congress, this emphasizes the innovationand the potential of this approach to fight cancer." Journalists interested in joining the press conference pleasecontact <a target="_blank" href="mailto:medi......ass, oralanticancer agent that modulates AKT and a number of other keysignal transduction pathways, includin...1, may beforward-looking statements that involve a number of risks anduncertainties. For those statements, we claim the protection of thesafe harbor for forwa......8 percent responserate in relapsed patients. "The number of options available to treat myeloma patients todayis growing with positive results from mature studies, as well aspreliminary results from smaller trials," said Brian G.M. Durie,M.D. chairman and co- founder of the IMF. "What we are learningfrom us...CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
...sses andelevation of CRP has been established in a number ofimmuno-inflammatory diseases, including RA. Conference Call Information CombinatoRx management will host a conference call to discussthese results at 8:30 a.m. ET on Thursday, June 28, 2007. To accessthe call, please dial 800.591.6930 (domestic) ......tements. Such forward-looking statements involve a number ofrisks and uncertainties and investors are cautio....In particular, Cytogen's business is subject to a number ofsignificant risks, which include, but are not limited to: the riskof obtaining the necessary regul...CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
...cebo-controlled and is planned to include a larger number ofvolunteers, treated for a longer period of time with a four-foldhigher dose than that used in the open-label clinical trial." The open-label extension clinical trial was initiated inFebruary 2006 as ALS volunteers completing CytRx'splacebo-control......0.0001 vs. placebo+metformin). In this study, the number of subjects with investigator-reportedhypoglycemia, with or without confirmation, were: 9 onplacebo+metformin, and 15, 10 and 7, for 2.5 mg, 5 mg, and 10 mg onsaxagliptin+metformin, respectively. There was one subject withconfirmed hypoglycemia in ea.......0001 vs. placebo+metformin). In this study, the number of subjects with investigator-reportedhypoglycemia, with or without confirmation, were: 9 onplacebo+metformin, and 15, 10 and 7, for 2.5 mg, 5 mg, and 10 mg onsaxagliptin+metformin, respectively. There was one subject withconfirmed hypoglycemia in e......ffect the aging process in mammalsand increase the number and function of mitochondria. According to the ...ur pipeline of SIRT1 modulators designedto treat a number of diseases of aging such as metabolic andmitochondrial disorders, and now neurological disorders." ...